[1] MOUSAVI SM, HEMMINKI K. Cancer incidence, trends, and survival among immigrants to Sweden: a population-based study[J]. Eur J Cancer Prev, 2015, 24(1): S1.
[2] MCMULLEN CP, SMITH RV. Treatment/Comparative therapeutics: cancer of the larynx and hypopharynx[J]. Surg Oncol Clin N Am, 2015, 24(3): 521. doi: 10.1016/j.soc.2015.03.013
[3] FUNK RT, JABBOUR J, ROBEY T. Factors associated with tracheotomy and decannulation in pediatric bilateral vocal fold immobility[J]. Int J Pediatr Otorhinolaryngol, 2015, 79(6): 895. doi: 10.1016/j.ijporl.2015.03.026
[4] ZHANG M, GAO XS, QIN Y, et al. Survival differences between definitive radiotherapy and surgery followed by adjuvant radiotherapy in supraglottic and hypopharyngeal carcinoma[J]. Chin Med J(Engl), 2019, 132(22): 2698.
[5] 米哲涛, 臧志方, 张秀甫, 等. 同期放化疗治疗局部晚期下咽癌的临床观察[J]. 肿瘤研究与临床, 2017, 29(11): 773. doi: 10.3760/cma.j.issn.1006-9801.2017.11.014
[6] KRSTEVSKA V, STOJKOVSKI I, ZAFIROVA-IVANOVSKA B, et al. Prognostic factors in patients with advanced hypopharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy[J]. J BUON, 2012, 17(2): 327.
[7] CHUNG EJ, LEE SH, BAEK SH, et al. Pattern of cervical lymph node metastasis in medial wall pyriform sinus carcinoma[J]. Laryngoscope, 2014, 124(4): 882. doi: 10.1002/lary.24299
[8] HANAI N, OZAWA T, HIRAKAWA H, et al. The nodal response to chemoselection predicts the risk of recurrence following definitive chemoradiotherapy for pharyngeal cancer[J]. Acta Otolaryngol, 2014, 134(8): 865. doi: 10.3109/00016489.2014.894252
[9] WANG YL, FENG SH, ZHU J, et al. Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: a population-based analysis[J]. PLoS One, 2013, 8(2): e56613. doi: 10.1371/journal.pone.0056613
[10] 蒋勤娟, 史雪飞, 陈胜东. 局部中晚期下咽癌28例放射治疗临床分析[J]. 全科口腔医学杂志, 2017, 4(18): 73. doi: 10.3969/j.issn.2095-7882.2017.18.039